razoxane has been researched along with Rhabdomyosarcoma in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andrich, MP; Avila, N; Balis, FM; Berg, SL; Chen, CC; Dilsizian, V; Horowitz, ME; Jarosinski, P; Poplack, DG; Venzon, D; Weaver-McClure, L; Wexler, LH | 1 |
Cocker, HA; Kelland, LR; Pinkerton, CR; Pritchard-Jones, K; Tiffin, N | 1 |
1 trial(s) available for razoxane and Rhabdomyosarcoma
Article | Year |
---|---|
Randomized trial of the cardioprotective agent ICRF-187 in pediatric sarcoma patients treated with doxorubicin.
Topics: Adolescent; Adult; Antibiotics, Antineoplastic; Cardiovascular Agents; Child; Doxorubicin; Female; Heart; Humans; Injections, Intravenous; Male; Neuroectodermal Tumors, Primitive, Peripheral; Razoxane; Rhabdomyosarcoma; Sarcoma; Sarcoma, Ewing; Soft Tissue Neoplasms; Stroke Volume; Survival Rate; Transaminases | 1996 |
1 other study(ies) available for razoxane and Rhabdomyosarcoma
Article | Year |
---|---|
In vitro prevention of the emergence of multidrug resistance in a pediatric rhabdomyosarcoma cell line.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Child; Cisplatin; Cyclosporins; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Etoposide; Gene Expression Regulation, Neoplastic; Humans; Indomethacin; Inhibitory Concentration 50; Piperidines; Pyridines; Quinolines; Razoxane; Rhabdomyosarcoma; RNA, Neoplasm; Staurosporine; Time Factors; Tumor Cells, Cultured; Vincristine | 2001 |